Psychometric properties of the eight-item Morisky Medication Adherence Scale (MMAS-8) in a psychiatric outpatient setting

  1. Carlos De las Cuevas 1
  2. Wenceslao Peñate 1
  1. 1 Universidad de La Laguna
    info

    Universidad de La Laguna

    San Cristobal de La Laguna, España

    ROR https://ror.org/01r9z8p25

Revista:
International journal of clinical and health psychology

ISSN: 1697-2600

Año de publicación: 2015

Volumen: 15

Número: 2

Páginas: 121-129

Tipo: Artículo

DOI: 10.1016/J.IJCHP.2014.11.003 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: International journal of clinical and health psychology

Referencias bibliográficas

  • Al-Qazaz H.Kh., Hassali M.A., Shafie A.A., Sulaiman S.A., Sundram S., Morisky D.E. The eight-item Morisky Medication Adherence Scale MMAS: Translation and validation of the Malaysian version. Diabetes Research and Clinical Practice 2010, 90:216-221. 10.1016/j.diabres.2010.08.012.
  • Bäßler J., Schwarzer R. Evaluación de la autoeficacia: adaptación española de la escala de autoeficacia general [Measuring generalized self-beliefs: A Spanish adaptation of the General Self-Efficacy scale]. Ansiedad y Estrés 1996, 2:1-8.
  • Choo P.W., Rand C.S., Inui T.S., Lee M.L., Cain E., Cordeiro-Breault M., Canning C., Platt R. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Medical Care 1999, 37:846-857.
  • De las Cuevas C., Peñate W., Betancort M., De Rivera L. Psychological reactance in psychiatric patients: Examining the dimensionality and correlates of the Hong Psychological Reactance Scale in a large clinical sample. Personality and Individual Differences 2014, 70:85-91. 10.1016/j.paid.2014.06.027.
  • De Oliveira-Filho A.D., Morisky D.E., Neves S.J., Costa F.A., De Lyra D.P. The 8-item Morisky Medication Adherence Scale: Validation of a Brazilian-Portuguese version in hypertensive adults. Research in Social and Administrative Pharmacy 2014, 10:554-561. 10.1016/j.sapharm.2013.10.006.
  • Doku-Ramírez A., Fonseca-Parra L.F., González-Gil E.J., Gualdrón-Alba J.C., Cifuentes-Villalobos C.E. Evaluación del Locus de control y su relación con las variables ansiedad y depresión en un grupo de asistentes a atención psicológica. Assessment of Locus of control and its relation to anxiety and depression variables in a group of participants in psychological care 2012, Universidad de La Sabana, Bogotá, Colombia.
  • Fabbrini G., Abbruzzese G., Barone P., Antonini A., Tinazzi M., Castegnaro G., Rizzoli S., Morisky D.E., Lessi P., Ceravolo R. Adherence to anti-Parkinson drug therapy in the REASON sample of Italian patients with Parkinson's disease: The linguistic validation of the Italian version of the Morisky Medical Adherence Scale-8 items. Neurological Sciences 2013, 34:2015-2022. 10.1007/s10072-013-1438-1.
  • Geddes J.R., Carney S.M., Davies C. Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review. Lancet 2003, 361:653-661.
  • Gupta S., Goren A. Application of Item Response Theory in validating The Morisky Medication Adherence Scale in patients with hypertension. Value in Health 2013, 16:A4. 10.1016/j.jval.2013.03.024.
  • Hacihasanoğlu Aşilar R., Gözüm S., Capik C., Morisky D.E. Reliability and validity of the Turkish form of the eight-item Morisky medication adherence scale in hypertensive patients. Anadolu Kardiyoloji Dergisi 2014, 10.5152/akd.2014.4982.
  • Hartley J. Some thoughts on Likert-type scales. International Journal of Clinical and Health Psychology 2014, 14:83-86. 10.1016/S1697-2600(14)70040-7.
  • Hogan T.P., Awad A.G., Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychological Medicine 1983, 13:177-183.
  • Hong S.M., Faedda S. Refinement of the Hong psychological reactance scale. Educational and Psychological Measurement 1996, 56:173-182.
  • Julius R.J., Novitsky M.A., Dubin W.R. Medication adherence: A review of the literature and implications for clinical practice. Journal of Psychiatric Practice 2009, 15:34-44. 10.1097/01.pra.0000344917.43780.77.
  • Kim J.H., Lee W.Y., Hong C.A., Hong Y.P., Ryu W.S., Lee K.J., Lee W.S., Morisky D.E. Psychometric properties of a short self-reported measure of medication adherence among patients with hypertension treated in a busy clinical setting in Korea. Journal of Epidemiology 2014, 24:132-140. 10.2188/jea.JE20130064.
  • Korb-Savoldelli V., Gillaizeau F., Pouchot J., Lenain E., Postel-Vinay N., Plouin P.F., Durieux P., Sabatier B. Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults. The Journal of Clinical Hypertension (Greenwich) 2012, 14:429-434. 10.1111/j. 1751-7176.2012.00634.x.
  • Morisky D.E., Ang A., Krousel-Wood M., Ward H.J. Predictive validity of a medication adherence measure in an outpatient setting. The Journal of Clinical Hypertension 2008, 10:348-354. 10.1111/j. 1751-7176.2008.07572.x.
  • Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care 1986, 24:67-74.
  • Nielsen R.E., Lindström E., Nielsen J., Levander S. DAI-10 is as good as DAI-30 in schizophrenia. European Neuropsychopharmacology 2012, 22:747-750. 10.1016/j.euroneuro.2012.02.008.
  • Osterberg L., Blaschke T. Adherence to medication. New England Journal of Medicine 2005, 353:487-497. 10.1056/NEJMra050100.
  • Pemberton R., Wainwright T. The end of mental illness thinking?. International Journal of Clinical and Health Psychology 2014, 14:216-220. 10.1016/j.ijchp.2014.05.003.
  • Roberts J., Turner N. Pharmacodynamic basis for altered drug action in the elderly. Clinics in Geriatric Medicine 1988, 4:127-149.
  • Robles R., Fresán A., Evans S.C., Lovell A.M., Medina-Mora M.L., Maj M., Reed G.F. Problematic, absent and stigmatizing diagnoses in current mental disorders classifications: Results from the WHO-WPA and WHO-IUPsyS Global Surveys. International Journal of Clinical and Health Psychology 2014, 14:165-177. 10.1016/j.ijchp.2014.03.003.
  • Robles García R., Salazar Alvarado V., Páez Agraz F., Ramírez Barreto F. Evaluación de actitudes al medicamento en pacientes con esquizofrenia: propiedades psicométricas de la versión en español del DAI [Evaluation of attitudes toward medication in patients with schizophrenia: psychometric properties of the Spanish version of the DAI]. Actas Españolas de Psiquiatría 2004, 32:138-142.
  • Sakthong P., Chabunthom R., Charoevisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes. Annals of Pharmacotherapy 2009, 43:950-957. 10.1345/aph.1L453.
  • Sanjuán P., Pérez A., Bermúdez J. Escala de autoeficacia general: datos psicométricos de la adaptación para población española. Psicothema 2000, 12:509-513.
  • Schwarzer R., Jerusalem M. Generalized Self-Efficacy scale. Measures in health psychology: A user's portfolio. Causal and control beliefs 1995, 35-37. NFER-NELSON, Windsor, England. J. Weinman, S. Wright, M. Johnston (Eds.).
  • Shelly A., Vik C., Maxwell J. Assessing medication adherence among older persons in community settings. The Canadian Journal of Clinical Pharmacolology 2005, 12:e152-e164.
  • Smith N.L., Psaty B.M., Heckbert S.R., Tracy R.P., Cornell E.S. The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly. Journal of Clinical Epidemiology 1999, 52:143-146.
  • Södergârd B., Halvarsson M., Tully M.P., Mindouri S., Nordström M.L., Lindbäck S. Adherencet ot reatment in Swedish HIV-infected patients. Journal of Clinical Pharmacy and Therapeutics 2006, 31:605-616.
  • Timimi S. No more psychiatric labels: Why formal psychiatric diagnostic systems should be abolished. International Journal of Clinical and Health Psychology 2014, 14:208-215. 10.1016/j.ijchp.2014.03.004.
  • Velligan D., Sajatovic M., Valenstein M., Riley W.T., Safren S., Lewis-Fernandez R., Weiden P., Ogedegbe G., Jamison J. Methodological challenges in psychiatric treatment adherence research. Clinical Schizophrenia & Related Psychoses 2010, 4:74-91. 10.3371/CSRP.4.1.6.
  • Velligan D.I., Weiden P.J., Sajatovic M., Scott J., Carpenter D., Ross R., Docherty J.P. The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness. Journal of Clinical Psychiatry 2009, 70(Suppl. 4):1-46. 10.4088/JCP.7090su1cj.
  • Voils C.I., Hoyle R.H., Thorpe C.T., Maciejewski M.L., Yancy W.S. Improving the measurement of self-reported medication nonadherence. Journal of Clinical Epidemiology 2011, 64:250-254. 10.1016/j.jclinepi.2010.07.014.
  • Wallston K.A., Stein M.J., Smith C.A. Form C of the MHLC scales: A condition-specific measure of locus of control. Journal of Personality Assessment 1994, 63. 534-353.
  • Wang Y., Kong M.C., Ko Y. Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin. Thrombosis and Haemostais 2012, 108:789-795. 10.1160/TH12-05-0368.
  • Yan J., You L.-M., Yang Q., Liu B., Jin S., Zhou J., Lin C., Morisky D.E. Translation and validation of a Chinese version of the 8-item Morisky medication adherence scale in myocardial infarction patients. Journal of Evaluation in Clinical Practice 2014, 20:311-317. 10.1111/jep.12125.